Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Non-Vested Options (Detail)

v3.22.2
Stockholders' Equity - Summary of Non-Vested Options (Detail) - $ / shares
6 Months Ended
May 31, 2022
May 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]    
Non-vested at November 30, 2021, Shares 63,034  
Granted, Shares 52,500  
Vested, Shares (14,204)  
Forfeited, Shares (4,416)  
Non-vested at May 31, 2022, Shares 96,914  
Non-vested at November 30, 2021, Weighted Average Grant-Date Fair Value $ 4.99  
Granted, Weighted Average Grant-Date Fair Value 4.56 $ 4.56
Vested, Weighted Average Grant-Date Fair Value 5.67  
Forfeited, Weighted Average Grant-Date Fair Value 7.98  
Non-vested at May 31, 2022, Weighted Average Grant-Date Fair Value $ 4.52